IndraLab

Statements


Lonafarnib leads to the farnesylation of KRAS. 1 / 1
| 1

reach
"Lonafarnib, which inhibits the farnesylation (and thus cell membrane targeting and function) of Kras, as well as the MEK inhibitor PD0325901 inhibited cell proliferation and the phosphorylation of FADD (XREF_FIG)."